Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rocio Lopez Cavestany

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Pathogens (Basel, Switzerland)|April 26, 2024
The Last Mile in Polio Eradication: Program Challenges and PerseveranceRocio Lopez Cavestany, Martin Eisenhawer, Ousmane M Diop, et al.
Journal of Cell Science|July 29, 2021
Three-dimensional geometry controls division symmetry in stem cell coloniesAgathe Chaigne, Matthew B Smith, Rocio Lopez Cavestany, et al.
Vaccine|February 2, 2024
Safety of incidental exposure to the novel oral poliovirus vaccine type 2 in pregnancy: A longitudinal observational study in Mozambique, 2022-2023Nilsa de Deus, Assucênio Chissaque, Adilson Bauhofer, et al.
The Lancet Regional Health. Southeast Asia|February 4, 2025
Post-vaccination campaign evaluation of systemic and mucosal immunity of trivalent oral poliovirus vaccine in Karachi, Pakistan (2020-2021): a cross-sectional studyAli Faisal Saleem, Visalakshi Jeyaseelan, Zaubina Kazi, et al.
The Lancet. Infectious Diseases|November 28, 2023
Use of inactivated poliovirus vaccine for poliovirus outbreak responseAnanda S Bandyopadhyay, Rocio Lopez Cavestany, Isobel M Blake, et al.
The Journal of Infectious Diseases|January 9, 2024
Mucosal Immunity to Poliovirus in Children 0-15 Years of Age: A Community-Based Study in Karachi, Pakistan in 2019Ali Faisal Saleem, Zaubina Umar Kazi, Syeda Mahjabeen Zehra, et al.
The Journal of Infectious Diseases|June 27, 2023
Two-Year Duration of Immunity of Inactivated Poliovirus Vaccine: A Follow-up Study in Pakistan in 2020Ali Faisal Saleem, Sadia Parkar, Syeda Mahjabeen Zehra, et al.
Vaccine: X|December 23, 2022
Community-based survey to assess seroprevalence of poliovirus antibodies in far-north Cameroon in 2020Marie Claire Endegue, Carolyn Sein, Rocio Lopez Cavestany, et al.
Eclinicalmedicine|December 24, 2025
Intramuscular versus intradermal administration of fractional dose inactivated poliovirus vaccine in Mozambique, 2020-2022: an, open-label, non-inferiority, randomised, controlled phase 2 trialEdna Omar Viegas, Emilia Fumane, Kassia Pereira, et al.
The Lancet Regional Health. Western Pacific|January 11, 2024
Poliovirus serological assay after the cVDPV1 outbreak in Papua New Guinea: a cross-sectional study from 2020 to 2021William Pomat, Rocio Lopez Cavestany, Visalakshi Jeyaseelan, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Pathogens (Basel, Switzerland)|April 26, 2024
The Last Mile in Polio Eradication: Program Challenges and PerseveranceRocio Lopez Cavestany, Martin Eisenhawer, Ousmane M Diop, et al.
Journal of Cell Science|July 29, 2021
Three-dimensional geometry controls division symmetry in stem cell coloniesAgathe Chaigne, Matthew B Smith, Rocio Lopez Cavestany, et al.
Vaccine|February 2, 2024
Safety of incidental exposure to the novel oral poliovirus vaccine type 2 in pregnancy: A longitudinal observational study in Mozambique, 2022-2023Nilsa de Deus, Assucênio Chissaque, Adilson Bauhofer, et al.
The Lancet Regional Health. Southeast Asia|February 4, 2025
Post-vaccination campaign evaluation of systemic and mucosal immunity of trivalent oral poliovirus vaccine in Karachi, Pakistan (2020-2021): a cross-sectional studyAli Faisal Saleem, Visalakshi Jeyaseelan, Zaubina Kazi, et al.
The Lancet. Infectious Diseases|November 28, 2023
Use of inactivated poliovirus vaccine for poliovirus outbreak responseAnanda S Bandyopadhyay, Rocio Lopez Cavestany, Isobel M Blake, et al.
The Journal of Infectious Diseases|January 9, 2024
Mucosal Immunity to Poliovirus in Children 0-15 Years of Age: A Community-Based Study in Karachi, Pakistan in 2019Ali Faisal Saleem, Zaubina Umar Kazi, Syeda Mahjabeen Zehra, et al.
The Journal of Infectious Diseases|June 27, 2023
Two-Year Duration of Immunity of Inactivated Poliovirus Vaccine: A Follow-up Study in Pakistan in 2020Ali Faisal Saleem, Sadia Parkar, Syeda Mahjabeen Zehra, et al.
Vaccine: X|December 23, 2022
Community-based survey to assess seroprevalence of poliovirus antibodies in far-north Cameroon in 2020Marie Claire Endegue, Carolyn Sein, Rocio Lopez Cavestany, et al.
Eclinicalmedicine|December 24, 2025
Intramuscular versus intradermal administration of fractional dose inactivated poliovirus vaccine in Mozambique, 2020-2022: an, open-label, non-inferiority, randomised, controlled phase 2 trialEdna Omar Viegas, Emilia Fumane, Kassia Pereira, et al.
The Lancet Regional Health. Western Pacific|January 11, 2024
Poliovirus serological assay after the cVDPV1 outbreak in Papua New Guinea: a cross-sectional study from 2020 to 2021William Pomat, Rocio Lopez Cavestany, Visalakshi Jeyaseelan, et al.
Pageof 2